UK markets close in 1 hour 26 minutes

Quest PharmaTech Inc. (QPT.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.03000.0000 (0.00%)
As of 03:53PM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 5.07M
Enterprise value 5.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.08
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.27

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 3-62.50%
S&P500 52-week change 323.10%
52-week high 30.1100
52-week low 30.0200
50-day moving average 30.0308
200-day moving average 30.0526

Share statistics

Avg vol (3-month) 39.29k
Avg vol (10-day) 318.05k
Shares outstanding 5169.13M
Implied shares outstanding 6169.13M
Float 8138.75M
% held by insiders 117.12%
% held by institutions 10.00%
Shares short (15 Apr 2024) 4530
Short ratio (15 Apr 2024) 40
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.00%
Shares short (prior month 31 Jan 2024) 45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 467.86
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 421 Jul 2005
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Jan 2023
Most-recent quarter (mrq)31 Oct 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-0.94%
Return on equity (ttm)-28.86%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -1.18M
Net income avi to common (ttm)-22.26M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)93.96k
Total cash per share (mrq)0
Total debt (mrq)1M
Total debt/equity (mrq)1.51%
Current ratio (mrq)0.26
Book value per share (mrq)0.39

Cash flow statement

Operating cash flow (ttm)-477.74k
Levered free cash flow (ttm)-147.28k